Patents by Inventor Stephen Tickle

Stephen Tickle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230241069
    Abstract: The present disclosure relates to a formulation of sapropterin. The formulation comprises a solid suspension of sapropterin dispersed within an oil. Methods of treatment using the formulation are also contemplated by the present disclosure.
    Type: Application
    Filed: February 2, 2023
    Publication date: August 3, 2023
    Applicant: APR Applied Pharma Research SA
    Inventors: Christopher WAGSTAFF, Stephen TICKLE
  • Publication number: 20140311929
    Abstract: A pharmaceutical dosage form comprising solid liquid components comprising solid and liquid components; the solid component comprising omeprazole as active ingredient; one or more water soluble excipients; wherein the liquid component comprises: a surfactant; water and optional further excipients.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 23, 2014
    Applicant: Nupharm Laboratories Limited
    Inventors: Stephen Tickle, William Michael Gould
  • Publication number: 20080102039
    Abstract: A spray foaming dosage form comprising betamethasone valerate, dimethyl isosorbide, propylene glycol, non ionic surfactant, sodium dodecyl sulphate, a buffer, optional preservative, optional further excipients, and water.
    Type: Application
    Filed: January 24, 2007
    Publication date: May 1, 2008
    Inventor: Stephen Tickle
  • Publication number: 20080102038
    Abstract: A spray foaming dosage form comprising clobetasol propionate, dimethyl isosorbide, propylene glycol, polysorbate, sodium dodecyl sulphate, buffer, optional preservative, optional further excipients, and water.
    Type: Application
    Filed: January 24, 2007
    Publication date: May 1, 2008
    Inventor: Stephen Tickle
  • Publication number: 20050079139
    Abstract: A pharmaceutical foam formulation in a dosage form which comprises an active ingredient selected from the group consisting of minoxidil, minoxidil sulphate, other soluble minoxidil salts, and mixtures thereof. An embodiment also includes a surfactant, water, and optional further excipients. In an embodiment, the formulation is adapted to form a foam when administered by spraying.
    Type: Application
    Filed: October 8, 2004
    Publication date: April 14, 2005
    Inventors: Elizabeth Jacques, Stephen Tickle